Treatment of advanced Hodgkin's disease with chemotherapy and irradiation. Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations.

[1]  S. Hellman,et al.  Influence of mediastinal adenopathy on site and frequency of relapse in patients with Hodgkin's disease. , 1982, Cancer treatment reports.

[2]  A. Santoro,et al.  Alternating drug combinations in the treatment of advanced Hodgkin's disease. , 1982, The New England journal of medicine.

[3]  S. Rosenberg,et al.  The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience. , 1982, Blood.

[4]  J. Bertino,et al.  Curative potential of combined modality therapy for advanced Hodgkin's disease , 1980, Cancer.

[5]  B. Clarkson,et al.  The eight‐drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease. A follow‐up report , 1980, Cancer.

[6]  R. Dinsmore,et al.  Fatal graft-versus-host disease following blood transfusion in Hodgkin's disease documented by HLA typing , 1980 .

[7]  A. Santoro,et al.  Second malignancies in Hodgkin's disease: a complication of certain forms of treatment. , 1980, British medical journal.

[8]  S. Rosenberg,et al.  Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. , 1979, The New England journal of medicine.

[9]  E. Glatstein,et al.  Hematologic neoplasia in patients treated for Hodgkin's disease. , 1977, The New England journal of medicine.

[10]  C. Young,et al.  Combination chemotherapy of MOPP‐resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV) , 1977, Cancer.

[11]  C. Bloomfield,et al.  Combined chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP , 1976 .

[12]  S. Pavlovsky,et al.  Combined cyclophosphamide, vincristine, procarbazine, and prednisone (copp) therapy of malignant lymphoma. Evaluation of 190 patients , 1975, Cancer.

[13]  G. Bonadonna,et al.  Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP , 1975, Cancer.

[14]  M. Slavik,et al.  Review of CCNU in clinical cancer therapy , 1974 .

[15]  E. Gehan,et al.  Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission. , 1973, Annals of internal medicine.

[16]  M. Pike,et al.  Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. , 1973, Biometrics.

[17]  M Tubiana,et al.  Report of the Committee on Hodgkin's Disease Staging Classification. , 1971, Cancer research.

[18]  V. Devita,et al.  Combination chemotherapy in the treatment of advanced Hodgkin's disease. , 1970, Annals of internal medicine.

[19]  L. Craver,et al.  Report of the Nomenclature Committee , 1966 .

[20]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[21]  R. Wittes,et al.  Phase II trial of vindesine in patients with malignant melanoma. , 1980, Cancer treatment reports.